Step Therapy and Fail-First Policies: Why PI Patients Need Pharmacy Liens

James Wong — Founder & CEO, LienScripts | March 4, 2026 | 7 min read

Step therapy protocols force personal injury patients to fail on cheaper medications before accessing the drugs their doctors prescribe. LienScripts pharmacy liens eliminate step therapy requirements entirely, giving patients immediate access to clinically appropriate treatment.

Step therapy, also known as fail-first protocol, is an insurance utilization management tool that requires patients to try and fail on one or more lower-cost medications before the insurer will approve coverage for the medication the prescriber originally ordered. For personal injury plaintiffs, step therapy creates medically inappropriate treatment delays because injury-related pain and inflammation require prompt, targeted treatment rather than a trial-and-error approach dictated by insurance economics. Pharmacy lien services through LienScripts eliminate step therapy entirely because medications are dispensed without insurance involvement.

• Step therapy requires patients to fail on cheaper drugs before insurers approve the prescribed medication
• Personal injury patients face 2-8 weeks of inadequate treatment during step therapy protocols
• LienScripts pharmacy liens dispense medications based on the prescriber's clinical judgment, not insurance formulary tiers
• Documented step therapy delays strengthen demand package narratives about treatment barriers
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages

How Step Therapy Works

When a prescriber writes a prescription for a medication that is not on the insurer's preferred tier, the insurer may require step therapy. The patient must first take a preferred (usually cheaper) medication for a specified period, typically 30 to 60 days. Only after documented failure on the step-one medication will the insurer approve the originally prescribed drug.

For example, a prescriber orders pregabalin for nerve pain from a car accident injury. The insurer requires the patient to try gabapentin first. If gabapentin does not adequately control the pain after 30 days, the insurer will then consider approving pregabalin. During those 30 days, the patient suffers with suboptimal pain control.

According to James Wong, PharmD, founder of LienScripts, "Step therapy makes sense for chronic disease management where time is on the patient's side. It makes no sense for acute injury treatment. A personal injury patient in pain needs the right medication now, not after weeks of failing on a medication the prescriber already determined was not the best choice."

Why Step Therapy Is Particularly Harmful in PI Cases

Acute Pain Requires Prompt Treatment

Personal injury patients present with acute conditions that demand immediate, appropriate pharmacotherapy. Requiring a patient with severe post-accident muscle spasms to try a milder muscle relaxant first, when the prescriber has clinical reasons for choosing a specific agent, delays effective pain management during the critical early treatment window.

Treatment Gaps Undermine Cases

Every day a plaintiff goes without adequate pain control is a day that the defense may later argue the pain was not severe enough to require aggressive treatment. Step therapy creates a documentation problem: the medical record shows the patient on a medication that was not the prescriber's first choice, potentially creating ambiguity about treatment necessity.

Failure Documentation Takes Time

The step therapy process requires documented clinical failure, which means follow-up appointments, symptom assessments, and additional prescriber time. For patients already managing injury-related medical appointments, adding step therapy compliance visits increases the treatment burden.

Multiple Step Therapy Requirements Compound

A personal injury patient may need several medications that each require step therapy. Anti-inflammatory medications, muscle relaxants, nerve pain agents, and sleep medications may each have separate step therapy protocols. The cumulative delay can extend treatment gaps by months.

How Pharmacy Liens Eliminate Step Therapy

The LienScripts pharmacy lien operates outside the insurance system. When a personal injury patient enrolls in the program:

• The prescriber writes the prescription based on clinical assessment
• The pharmacy fills the prescription as written, with no insurance adjudication
• No step therapy, prior authorization, or formulary tier applies
• The patient receives the clinically appropriate medication immediately
• The lien attaches to the settlement proceeds for cost recovery

This approach ensures the prescriber's clinical judgment drives treatment decisions, not insurance cost management protocols.

Attorneys managing pre-litigation medication strategy should establish pharmacy liens at the start of representation to prevent any step therapy delays from occurring.

Documenting Step Therapy Delays for Case Value

When a client experienced step therapy delays before enrolling in the pharmacy lien, those delays become part of the case narrative. Attorneys should document:

The original prescription date. When did the prescriber first order the medication that was subject to step therapy?

The step therapy requirement. What alternative medication did the insurer require the patient to try first?

Duration of inadequate treatment. How many days or weeks did the patient take the step-one medication before the prescriber documented clinical failure?

Patient impact during the delay. What symptoms did the patient experience during the step therapy period? How did inadequate pain control affect daily activities, work, and quality of life?

The MERIT report from LienScripts documents the complete medication timeline once the patient enrolls in the lien program. Combined with prescriber records showing the pre-lien step therapy period, attorneys can build a comprehensive treatment barrier narrative.

State Step Therapy Reform

Several states have enacted step therapy reform laws that provide exception processes for acute conditions, previously tried medications, and situations where step therapy would cause irreversible harm. However, these exceptions require additional documentation and prescriber advocacy, adding administrative burden to an already complex process.

Attorneys should be aware of state-specific step therapy protections but should not rely on them as the primary solution for injured clients. The pharmacy lien provides certainty that no step therapy delay will occur, regardless of state law variations.

Practical Recommendations for Attorneys

Enroll clients in the LienScripts pharmacy lien program at the beginning of representation. Do not wait for step therapy problems to arise. Proactive enrollment ensures the prescriber can order the clinically appropriate medication from day one without insurance interference.

If a client has already experienced step therapy delays, document the timeline thoroughly and include it in the demand package as evidence of the treatment barriers the plaintiff overcame. This evidence strengthens the overall case narrative and supports the claim for full recovery of pharmacy lien amounts at settlement.